Blue Cell Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 39981610
Ole Maaløes Vej 3, 2200 København N
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -2 069.78 | - 843.70 | 852.13 | - 741.53 | -3 052.65 |
Employee benefit expenses | -12 007.23 | -8 474.46 | -11 642.95 | -14 195.72 | -12 785.68 |
Other operating expenses | - 873.82 | -5 845.13 | -3 735.73 | -2 986.32 | -1 539.57 |
Total depreciation | - 218.68 | - 273.58 | - 335.32 | - 163.37 | |
EBIT | -14 950.83 | -15 381.97 | -14 800.13 | -18 258.89 | -17 541.26 |
Other financial expenses | -41.07 | -51.45 | -64.46 | -3.51 | -9.98 |
Pre-tax profit | -14 991.90 | -15 433.43 | -14 864.59 | -18 262.41 | -17 551.25 |
Income taxes | 965.00 | 1 192.02 | 2 294.63 | 2 974.03 | 2 361.40 |
Net earnings | -14 026.90 | -14 241.41 | -12 569.96 | -15 288.37 | -15 189.85 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 602.06 | 328.48 | 269.50 | 176.71 | |
Tangible assets total | 602.06 | 328.48 | 269.50 | 176.71 | |
Investments total | 56.24 | 103.80 | 82.60 | 122.60 | |
Long term receivables total | |||||
Inventories total | |||||
Current trade debtors | 138.84 | ||||
Prepayments and accrued income | 6.46 | 118.65 | 36.77 | 99.84 | |
Current other receivables | 18 793.54 | 576.14 | 1 477.86 | 3 164.73 | 3 809.65 |
Current deferred tax assets | 965.00 | 2 157.02 | 4 451.65 | 2 973.95 | 2 361.32 |
Short term receivables total | 19 758.54 | 2 739.62 | 6 187.00 | 6 175.45 | 6 270.81 |
Cash and bank deposits | 9 745.55 | 10 606.82 | 4 005.38 | 3 631.63 | 7 554.32 |
Cash and cash equivalents | 9 745.55 | 10 606.82 | 4 005.38 | 3 631.63 | 7 554.32 |
Balance sheet total (assets) | 29 504.10 | 14 004.74 | 10 624.66 | 10 159.19 | 14 124.45 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 40.00 | 40.00 | 43.13 | 47.46 | 53.75 |
Share premium account | 29 962.00 | ||||
Other reserves | 16 000.00 | ||||
Retained earnings | -6 199.28 | 26 682.62 | 22 438.08 | 23 659.95 | 28 230.54 |
Profit of the financial year | -14 026.90 | -14 241.41 | -12 569.96 | -15 288.37 | -15 189.85 |
Shareholders equity total | 25 775.82 | 12 481.21 | 9 911.25 | 8 419.03 | 13 094.43 |
Non-current liabilities total | |||||
Current trade creditors | 963.40 | 885.33 | 327.89 | 668.23 | 573.82 |
Other non-interest bearing current liabilities | 514.88 | 638.19 | 385.51 | 1 071.92 | 456.20 |
Accruals and deferred income | 2 250.00 | ||||
Current liabilities total | 3 728.27 | 1 523.53 | 713.41 | 1 740.15 | 1 030.02 |
Balance sheet total (liabilities) | 29 504.10 | 14 004.74 | 10 624.66 | 10 159.19 | 14 124.45 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.